KALA BIO, Inc. (KALA) News & Corporate Actions | Announcements, Board Meetings, Splits, Bonuses, Rights Issues

{
  "main_header": {
    "sid": 1156471,
    "name": "KALA BIO, Inc.",
    "stock_name": "KALA BIO, Inc.",
    "full_name": "KALA BIO, Inc.",
    "name_url": "stocks-analysis/kala-bio-inc",
    "exchange": 210,
    "exchangecode": "NAS",
    "country_id": 2,
    "currency": "USD",
    "cmp": "0.96",
    "chg": -0.14,
    "chgp": "-12.36%",
    "dir": -1,
    "prev_price": "1.10",
    "mcapval": "101.66",
    "mcap": "",
    "scripcode": "",
    "symbol": "",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 2305,
    "indexname": "S&P 500",
    "isin": "US4831192020",
    "curr_date": "Dec 04",
    "curr_time": "",
    "bse_nse_vol": "20.0 M",
    "exc_status": "Active",
    "traded_date": "Dec 04, 2025",
    "traded_date_str": "2025 12 04",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-registerF-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/kala-bio-inc-1156471-210&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0
    }
  },
  "news": {
    "results": [
      {
        "title": "Is KALA BIO, Inc. technically bullish or bearish?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/is-kala-bio-inc-technically-bullish-or-bearish-3546561",
        "imagepath": "",
        "date": "2025-09-20 19:35:44",
        "description": "As of 20 August 2025, the technical trend for KALA BIO, Inc. has changed from mildly bullish to bullish. The current technical stance is bullish with strong indicators supporting this view, particularly in the daily moving averages and the weekly KST and OBV, both of which are bullish. However, the weekly and monthly RSI readings are bearish, suggesting some caution. The Bollinger Bands indicate a bullish stance on the monthly timeframe. \n\nIn terms of performance, KALA BIO has significantly outperformed the S&P 500 across multiple periods, with a 1-month return of 104.37% compared to the S&P 500's 2.33%, and a 1-year return of 202.33% versus 17.14%. Overall, the strength of the bullish trend is supported by the recent price action and strong returns relative to the benchmark...."
      },
      {
        "title": "KALA BIO, Inc. Hits New 52-Week High of $20.60",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/kala-bio-inc-hits-new-52-week-high-of-2060-3531406",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/9/KALABIOInc_priceRelatedfactors_3531406.png",
        "date": "2025-09-18 13:17:31",
        "description": "KALA BIO, Inc. has achieved a new 52-week high, reflecting significant growth over the past year. The company has outperformed the S&P 500 and boasts a notable return on equity, despite being unprofitable. With a market capitalization of USD 102 million, it maintains a balanced capital structure."
      },
      {
        "title": "KALA BIO, Inc. Hits New 52-Week High of $20.12, Up 195% Year-Over-Year",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/kala-bio-inc-hits-new-52-week-high-of-2012-up-195-year-over-year-3525839",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/9/KALABIOInc_priceRelatedfactors_3525839.png",
        "date": "2025-09-17 15:16:06",
        "description": "KALA BIO, Inc. has achieved a new 52-week high of USD 20.12, reflecting a substantial increase in stock performance over the past year. With a market capitalization of USD 102 million, the company operates in the Pharmaceuticals & Biotechnology sector and has demonstrated remarkable profitability metrics despite currently being loss-making."
      },
      {
        "title": "KALA BIO, Inc. Hits New 52-Week High of $19.69",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/kala-bio-inc-hits-new-52-week-high-of-1969-3519587",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/9/KALABIOInc_priceRelatedfactors_3519587.png",
        "date": "2025-09-16 11:24:12",
        "description": "KALA BIO, Inc. has achieved a new 52-week high, reflecting significant growth from its previous low. The company has seen a remarkable one-year gain, outpacing broader market performance. Despite being unprofitable, it showcases an extraordinary return on equity, while its financial metrics indicate a focus on growth over dividends."
      }
    ],
    "total": 9,
    "sid": "1156471",
    "stock_news_url": "https://www.marketsmojo.com/news/kala-bio-inc-1156471"
  },
  "announcements": "",
  "corporate_actions": {
    "msg": "No corporate action Found"
  }
}

News and Views

Is KALA BIO, Inc. technically bullish or bearish?

2025-09-20 19:35:44

As of 20 August 2025, the technical trend for KALA BIO, Inc. has changed from mildly bullish to bullish. The current technical stance is bullish with strong indicators supporting this view, particularly in the daily moving averages and the weekly KST and OBV, both of which are bullish. However, the weekly and monthly RSI readings are bearish, suggesting some caution. The Bollinger Bands indicate a bullish stance on the monthly timeframe. In terms of performance, KALA BIO has significantly outperformed the S&P 500 across multiple periods, with a 1-month return of 104.37% compared to the S&P 500's 2.33%, and a 1-year return of 202.33% versus 17.14%. Overall, the strength of the bullish trend is supported by the recent price action and strong returns relative to the benchmark....

KALA BIO, Inc. Hits New 52-Week High of $20.60

2025-09-18 13:17:31

KALA BIO, Inc. has achieved a new 52-week high, reflecting significant growth over the past year. The company has outperformed the S&P 500 and boasts a notable return on equity, despite being unprofitable. With a market capitalization of USD 102 million, it maintains a balanced capital structure.

KALA BIO, Inc. Hits New 52-Week High of $20.12, Up 195% Year-Over-Year

2025-09-17 15:16:06

KALA BIO, Inc. has achieved a new 52-week high of USD 20.12, reflecting a substantial increase in stock performance over the past year. With a market capitalization of USD 102 million, the company operates in the Pharmaceuticals & Biotechnology sector and has demonstrated remarkable profitability metrics despite currently being loss-making.

KALA BIO, Inc. Hits New 52-Week High of $19.69

2025-09-16 11:24:12

KALA BIO, Inc. has achieved a new 52-week high, reflecting significant growth from its previous low. The company has seen a remarkable one-year gain, outpacing broader market performance. Despite being unprofitable, it showcases an extraordinary return on equity, while its financial metrics indicate a focus on growth over dividends.

View All News